New York covid-19 vaccine prevention New York

Sorrento ties up with New York's Mount Sinai to develop Covid-19 antibody shield

Reading now: 328
www.livemint.com

Sorrento Therapeutics Inc on Friday partnered with New York City's Mount Sinai Health System to develop an antibody cocktail to potentially treat or prevent covid-19, with the aim of starting human trials in the third quarter.

There are currently no treatments or vaccines approved for the coronavirus and several drugmakers have been rushing to develop new treatments or repurpose existing drugs to treat patients.

Regeneron currently leads the effort to develop an antibody cocktail and has said its experimental therapy may be available for use as early as the end of summer as it ramps up efforts to start human trials in June.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA